Best Momentum Stock to Buy for September 30th
Zacks Investment Research highlights Stepan (SCL) and AC Immune (ACIU) as top momentum stocks to consider. Both companies have a Zacks Rank #1 (Strong Buy) and have shown significant earnings estimate increases and share price gains over the last three months, outperforming the S&P 500. These stocks are presented for investors seeking strong momentum characteristics.
Best Momentum Stock to Buy for September 30th
This article highlights two momentum stocks, Stepan (SCL) and AC Immune (ACIU), as strong buys for September 30th. Both companies have a Zacks Rank #1 (Strong Buy) and have shown significant earnings estimate revisions and stock price gains compared to the S&P 500.
Stepan Company rebounds with strong margin and sales growth, targeting 11.2% upside by 2028.
Stepan Company is showing strong recovery with significant margin and sales growth, particularly in North America. This is attributed to effective cost-saving strategies and robust demand in key sectors like data center construction. Analysts rate the stock as a Buy, projecting an 11.2% upside by 2028 due to its sustainable dividends, attractive valuation, and strategic growth initiatives.
Stepan lands $500M credit line, lifting borrowing capacity by $50M
Stepan Company has secured a new five-year, $500 million credit agreement, replacing a previous $450 million package. This deal, led by JPMorgan Chase Bank and Bank of America, increases the specialty chemicals maker's borrowing capacity by $50 million and extends its debt maturities. The new facility includes a $350 million multicurrency revolving credit line and a $150 million delayed draw term loan, providing liquidity for working capital, acquisitions, and general corporate purposes, with an option to expand to $750 million.
Stepan Company (SCL) Stock Price, News, Quote & History
This article provides a detailed overview of Stepan Company (SCL) stock, including its current price, historical performance, key financial metrics, and analyst insights. It covers the company's business segments—Surfactants, Polymers, and Specialty Products—and its global operations in specialty and intermediate chemicals. The report also includes recent news, performance over various periods, earnings trends, and valuation measures.
Stepan Company stock holds at USD 61.81 as Nasdaq gains
Stepan Company's stock closed at USD 61.81 on September 22, 2026, experiencing a slight decline of 0.11% while the broader Nasdaq Composite gained 2.26% to reach 27,122.09 points. This performance indicates that the technology-led market strength did not translate to Stepan Company, which operates in specialty chemicals. The article highlights the discrepancy between the stock's performance and its reported 52-week range, emphasizing the need for periodized company updates to assess earnings momentum.
Stepan Company stock edges lower after recent gains as investors watch latest results
Stepan Company's stock saw a slight decline after significant gains over the past year, closing at USD 61.78 on September 18, 2026. While revenue increased by approximately 4%, diluted earnings per share decreased by nearly 14%, raising concerns about margin pressure among investors. The company's market capitalization is in the mid-single-digit billion-dollar range, and investors are closely monitoring future earnings reports for signs of consistent earnings expansion.
Empowered Funds takes new $4.95M stake in chemical maker Stepan
Empowered Funds LLC has acquired a new stake of 88,869 shares, valued at $4.95 million, in Stepan Company, a global manufacturer of specialty chemicals. This investment follows Stepan's strong second-quarter earnings, where it surpassed revenue and EPS expectations. The move by Empowered Funds aligns with other institutional buyers increasing their holdings, despite mixed analyst sentiment, signaling renewed interest in the company.
Stepan Eyes Margin Recovery as Catalyst Targets $100M in Savings
Stepan (NYSE:SCL) is in the early stages of a margin recovery, driven by growth in higher-margin product areas, cost reductions through Project Catalyst, and broader volume gains. The company aims for $100 million in savings by 2027 through footprint optimization and workforce reductions, while prioritizing segments like crop productivity and oilfield chemicals. Stepan also plans to reduce leverage and achieve positive cash generation for the year.
Stepan Company VP Shawn Lisle Executes RSU Vesting and Tax Share Withholding on August 26, 2026
Shawn G. Lisle, VP, General Counsel, and Secretary of Stepan Company (NYSE:SCL), completed the settlement of 1,154 restricted stock units (RSUs) on August 26, 2026. He also executed share withholding for tax purposes, resulting in 339 shares being withheld. Following these transactions, Lisle directly holds 840.544 common shares and beneficially owns 2,308 outstanding RSUs that will vest evenly over three years.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company recently reported mixed financial results, showing stronger Q2 2026 earnings but a six-month net loss, while maintaining its quarterly dividend. The article discusses how these results impact Stepan's investment outlook, emphasizing the need for the company to convert its specialty chemicals assets into consistent earnings and cash flow. It also highlights the differing fair value estimates for SCL among investors and suggests further research into the company's financial health.
ETFs Investing in Stepan Co Stocks
This article lists various ETFs that include Stepan Co stocks in their portfolios, detailing each fund's market value, weight of Stepan Co stock, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total return. The information helps investors identify diversified options for investing in Stepan Co, primarily through small-cap focused ETFs.
Can Stepan (SCL) Trade At A Discount Without Looking Cheap?
Stepan (SCL) stock has recovered over the past year but still faces a significant 5-year decline. The current valuation suggests it is neither obviously cheap nor expensive, with its P/S ratio aligning closely with fair value models. While broader checks remain supportive for value investors, Stepan needs to demonstrate consistent cash generation and margin protection to justify its current valuation.
Can Stepan (SCL) Trade At A Discount Without Looking Cheap?
Stepan (SCL) stock has seen a recovery over the past year, but still faces a significant five-year decline. The current valuation, based on Simply Wall St's checks, suggests the shares are neither obviously cheap nor expensive, trading close to their fair P/S value of 0.6x. Future performance will depend on the company's ability to convert revenue into cash flow and maintain margins, making its current middling valuation a point of interest for value-oriented investors.
Stepan Number of Employees 2026 | Employee Count & Headcount Data
Stepan Co. (SCL) had approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. The company, headquartered in Northbrook, Illinois, is actively hiring but has seen a significant 60.9% decrease in active job postings from 2025 to 2026. North America holds the largest concentration of its workforce, and the average salary globally is $74,689.
Empowered Funds LLC Raises Stake in Stepan Company $SCL
Empowered Funds LLC significantly increased its stake in Stepan Company (NYSE:SCL) by 124.8% in the first quarter, now owning 174,376 shares valued at $8.7 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively holding 82.70% of the company's stock. Stepan recently reported strong quarterly earnings, beating analyst estimates with an EPS of $1.18 and a 15% year-over-year revenue increase, alongside declaring a quarterly dividend of $0.395 per share.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company exceeded analyst expectations in its second-quarter results, with revenues 7.6% above estimates and statutory earnings per share 133% ahead. Despite this, analysts are now forecasting a loss for 2026, a dip in sentiment from previous profit predictions, though the average price target increased by 13%. The company is projected to grow faster than the broader industry, with an 8.3% annualised revenue growth forecast until the end of 2026, significantly better than its 1.5% annual decline over the past five years.
Stepan Co (SCL) CFO settles RSUs into stock, withholds shares for taxes
Stepan Co's CFO, Ruben Dario Velasquez, settled 1,358 Restricted Stock Units (RSUs) into common stock at $64.675 per share on August 10, 2026. A total of 398 shares were withheld for tax liabilities, leaving 2,716 RSUs outstanding which will vest ratably over three years. This transaction was part of his equity compensation, and no Rule 10b5-1 trading plan was indicated.
Stronger Q2 Earnings And Maintained Dividend Might Change The Case For Investing In Stepan (SCL)
Stepan Company reported stronger Q2 2026 earnings with sales of US$684.11 million and net income of US$22.91 million, a positive shift despite a six-month net loss of US$18.50 million. The company maintained its quarterly dividend of US$0.395 per share, indicating a focus on shareholder returns amidst profitability and cash flow challenges. This mixed financial picture suggests investors should weigh the earnings rebound against ongoing cash flow risks when evaluating Stepan's investment prospects.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company (NYSE:SCL) exceeded Q2 revenue and EPS forecasts, reporting US$684m in revenue (7.6% above estimates) and US$1.00 EPS (133% above expectations). Analysts now predict revenues of US$2.53b for 2026, an improvement of 4.1% over the last 12 months, though they anticipate a loss of US$0.16 per share, a shift from previous profit forecasts. Despite the projected loss, the average price target rose 13% to 75, and Stepan is expected to grow faster than the industry average.
Wall Street Zen Upgrades Stepan (NYSE:SCL) to Buy
Wall Street Zen has upgraded Stepan (NYSE:SCL) from "hold" to "buy," despite MarketBeat's overall analyst consensus remaining "Reduce." This upgrade follows Stepan's strong quarterly earnings, where it surpassed EPS and revenue expectations, leading to a 1.8% rise in shares to $65.14. Institutional investors hold a significant 82.7% of the stock, with several major investors recently increasing their positions.
Stepan (SCL) After Q2 Results Has A Valuation Question Worth Watching
Stepan (SCL) recently reported Q2 2026 results with strong sales and net income, alongside affirming its quarterly dividend. The stock has shown recent momentum with a 13.18% 30-day return, though its 3-year total shareholder return is down. Despite a P/S ratio suggesting fair valuation compared to peers, a Discounted Cash Flow model indicates significant undervaluation.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company (NYSE:SCL) exceeded Q2 revenue and EPS expectations, reporting US$684m and US$1.00 respectively, significantly above analyst estimates. Despite the strong Q2 performance, analysts are now forecasting a loss for 2026, though the average price target increased, suggesting these losses might be temporary. The company is expected to outpace industry revenue growth, projected at 8.3% annually compared to the industry's 4.8%.
Stepan (SCL) After Q2 Results Has A Valuation Question Worth Watching
Stepan (SCL) recently reported Q2 2026 results with sales of US$684.11 million and net income of US$22.91 million, affirming a quarterly dividend. While the stock has seen recent momentum, its 3-year return is still down. The article explores Stepan's valuation, noting its 0.6x Price-to-Sales multiple is undervalued compared to peers and the industry, yet a Discounted Cash Flow model suggests an even larger undervaluation.
Stepan Company $SCL Shares Sold by Public Employees Retirement System of Ohio
Public Employees Retirement System of Ohio significantly reduced its stake in Stepan Company (NYSE: SCL) by 94.1% in the first quarter, selling over 27,000 shares. Despite this, institutional investors and hedge funds still own 82.7% of the company. Stepan reported strong quarterly earnings, beating estimates with a 15% revenue increase year-over-year, and declared a quarterly dividend of $0.395 per share.
Stepan (SCL) Posts Stronger Q2 Results And Affirms Dividend, Does The Stock Still Look Cheap?
Stepan (SCL) reported strong Q2 results, affirmed its dividend, and announced governance changes, leading to significant share price momentum. Despite recent gains and a period of unprofitability, the stock appears undervalued with a Price-to-Sales (P/S) ratio of 0.6x, compared to a fair P/S of 0.6x and higher industry averages. Both P/S analysis and a Discounted Cash Flow model suggest the stock is trading below its estimated fair value, but risks related to net losses and past shareholder returns remain.
How Stepan Company (SCL) Affects Rotational Strategy Timing
This article analyzes Stepan Company (SCL) and its impact on rotational trading strategies using AI models. It highlights weak near-term sentiment but potential long-term upside, providing specific institutional trading strategies including position, momentum breakout, and risk hedging with entry, target, and stop loss points. The analysis also includes multi-timeframe signal strengths and support/resistance levels for various holding periods.
How Stepan Company (SCL) Affects Rotational Strategy Timing
This article analyzes Stepan Company (SCL) and its impact on rotational trading strategies using AI models. It identifies weak near-term sentiment for SCL but strong mid- and long-term outlooks, with no resistance levels above the current price. The article details three institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) and provides multi-timeframe signal analysis, including support and resistance levels.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed financial results with stronger second-quarter earnings but a net loss for the first half of 2026. Despite this, the company reaffirmed its quarterly dividend, signaling a focus on capital returns. Analysts project significant revenue and earnings growth by 2029, suggesting a potential 17% upside to its current price.
STEPAN CO Q2 2026: Revenue $684.1M, EPS $1— 10-Q Summary
Stepan Co (SCL) reported strong second-quarter 2026 results, with revenue reaching $684.1 million and diluted earnings per share at $1.00. This performance was driven by a 15% year-over-year increase in revenue and a doubling of net income, primarily due to higher selling prices and improved product mix, especially in surfactants. The company also initiated "Project Catalyst" to improve operational efficiency and reduce costs.
Weekly Recap: Stepan Co Q2 sales and EBITDA rise and 100 salaried cuts
Stepan Co (NYSE:SCL) reported an increase in Q2 2026 sales and EBITDA, attributing the growth to organic volume, favorable product mix, higher prices, and savings from Project Catalyst. Despite this positive performance, the company warned of a potentially softer Q3 and announced plans to cut approximately 100 salaried positions, incurring restructuring charges of $75–$80 million, with a cash impact of $14–$18 million. Additionally, Stepan Co announced leadership changes, including a director's resignation and the appointment of a new Principal Accounting Officer.
Stepan (NYSE: SCL) VP Eaken reports direct and ESOP-held share ownership
Matthew John Eaken, VP, Controller & PAO of Stepan Company (NYSE: SCL), filed an initial statement of beneficial ownership. The report details his direct ownership of 9,319 common shares and indirect ownership of 3,102 shares through an ESOP II Trust. Additionally, the filing outlines his holdings in stock options, stock appreciation rights, performance shares, and restricted stock units, all tied to Stepan common stock with various vesting conditions and exercise prices.
Stepan Company $SCL Shares Bought by Sei Investments Co.
Sei Investments Co. significantly increased its stake in Stepan Company (NYSE:SCL) by 465.5% in the first quarter, now owning 123,800 shares valued at approximately $6.19 million. Stepan recently reported strong quarterly earnings, beating analyst expectations with an EPS of $1.18 and a 15% year-over-year revenue increase to $684.1 million. Despite this, analysts maintain a cautious "Reduce" consensus rating for the stock.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed Q2 2026 results, with stronger quarterly earnings but a six-month net loss of US$18.5 million. The company affirmed its quarterly dividend of US$0.395 per share, highlighting a focus on capital returns despite the year-to-date loss. Investors are watching for earnings normalization and improved cash flow, with revenue projected to reach US$2.8 billion and earnings US$137.8 million by 2029, suggesting a potential 17% upside to its current price.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed Q2 2026 results with stronger quarterly earnings but a six-month net loss, while affirming its quarterly dividend. This situation highlights the company's focus on capital returns amidst efforts to normalize earnings and manage costs, particularly regarding margin pressures in its Surfactants and Polymers segments. Investors are encouraged to consider diverse fair value estimates and a detailed analysis of the company's financial health to form their own investment verdicts.
Stepan (SCL) Stock Cools Even As Margin Repair Gains Force
Stepan (SCL) stock dropped 1.6% despite Q2 earnings showing significant margin repair with adjusted EBITDA rising to US$74.4m, an increase of about 45% year-over-year. Net sales reached US$684.1m, and adjusted EPS hit US$1.18, indicating a strong rebound in profitability. The market's reaction suggests focus on a modest pullback after a strong run, viewing the quarter as tidy rather than a full sentiment reset, while analysts note ongoing efforts from Project Catalyst and operational improvements.
Stepan Releases Q2 2026 Financial Results
Stepan Company reported strong Q2 2026 financial results, significantly exceeding Wall Street's earnings expectations. The company posted adjusted earnings of $1.18 per share, beating the consensus estimate by 90.3%, with revenue climbing to $684.1 million, an increase of 15.0% year-over-year. Surfactants were a key growth driver, and analysts maintain a positive outlook on the stock.
Stepan Declares Quarterly Dividend
Stepan Company (NYSE: SCL) has announced a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to stockholders of record on September 1, 2026. This marks the 58th consecutive year the company has increased its cash dividend. Stepan is a major manufacturer of specialty and intermediate chemicals, including surfactants and polyurethane polyols.
Stepan Releases Q2 2026 Financial Results
Stepan Company exceeded Wall Street expectations in Q2 2026, reporting adjusted earnings of $1.18 per share, significantly beating the $0.62 consensus. The specialty chemicals manufacturer saw revenue climb to $684.1M, a 15.0% increase year-over-year, driven by strong organic sales volume growth of 6.0% and strong performance in its surfactants division. Analysts maintain a positive stance on the stock, reflecting improved margins and operational execution.
Earnings Flash (SCL) Stepan Company Posts Q2 Adjusted EPS $1.18 per Share, Vs. FactSet Est of $0.61
Stepan Company (SCL) reported strong Q2 adjusted earnings per share of $1.18, significantly exceeding the FactSet estimate of $0.61. This indicates a robust financial performance by the company during the second quarter.
Stepan Co. (SCL) Surpasses Q2 Earnings and Revenue Estimates
Stepan Co. (SCL) reported strong Q2 results, with earnings of $1.18 per share against an estimate of $0.61, representing a +93.44% surprise. The company also surpassed revenue estimates, posting $684.11 million compared to a $594.69 million year-ago figure. While SCL shares have gained significantly year-to-date, their immediate future performance will largely depend on the management's outlook during the earnings call, with the stock currently holding a Zacks Rank #3 (Hold).
Stepan Company Q2 net income doubles on volume growth and margin recovery, plans workforce cuts.
Stepan Company reported a 102% increase in Q2 2026 net income to $22.9 million, driven by higher sales volumes, margin recovery, and efficiency gains. Adjusted EBITDA rose 45% year-over-year to $74.4 million, with strong growth in Surfactants and Polymers. The company also announced plans to reduce its global salaried workforce by approximately 100 positions as part of ongoing restructuring efforts.
Stepan Declares Quarterly Dividend
Stepan Company has announced a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to stockholders of record on September 1, 2026. This marks the 58th consecutive year the company has increased its cash dividend, following a $0.010 per share increase in Q4 2025. Stepan is a major manufacturer of specialty and intermediate chemicals, including surfactants and polyurethane polyols, used across various industries globally.
Stepan's Cash Dividend Streak Reaches 58 Consecutive Years
Stepan Company (NYSE: SCL) has declared a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026. This dividend marks the 58th consecutive year of dividend increases for the specialty and intermediate chemical manufacturer, a streak maintained by a $0.010 per share raise in the fourth quarter of 2025. The company emphasizes its role as a major global producer of surfactants and polyurethane polyols.
Stepan faces earnings test as restructuring plan unfolds By Investing.com
Stepan Company is set to release its second-quarter earnings, with analysts anticipating improved profitability driven by a cost-reduction program called Project Catalyst. Investors will be closely watching the progress of this restructuring plan, margin trends, and volume momentum across end markets. Despite a turbulent first quarter with a net loss due to restructuring charges, the company expects its efficiency plan to counteract margin pressures.
Stepan faces earnings test as restructuring plan unfolds By Investing.com
Stepan Company is set to report second-quarter earnings, with analysts anticipating improved profitability driven by a restructuring plan, Project Catalyst. Investors will focus on the progress of this cost-reduction initiative, margin trends indicating a shift to higher-value products, and volume momentum across end markets. The company's stock is priced for a turnaround, contingent on the successful execution and impact of its restructuring efforts.
Stepan Co (SCL) Valuation: PE, PB & Fair Value Analysis
Stepan Co (SCL) currently holds a valuation score of 8.90, ranking 16th out of 65 companies in the Chemicals industry. Its P/E ratio is -92.70, which is significantly below its recent high and slightly above its recent low. Other key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
SCL|Stepan Co|Price:57.500|Chg%:-0.070
This article provides a comprehensive stock analysis of Stepan Co (SCL) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation, ranking 12th in the Chemicals industry. Despite positive analyst ratings and institutional confidence, technical indicators suggest sideways trading. The analysis covers the company's financial health, valuation, earnings forecasts, price momentum, institutional confidence, and risk assessment, explaining how each score is generated.
Stepan Co (SCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a brief overview of Stepan Co (SCL)'s stock performance and a breakdown of its revenue by geographic region. The company's market capitalization is $1.30 billion, and its stock price is $57.570. The regional revenue data indicates that the United States contributes the largest proportion of revenue for Stepan Co, followed by France and other countries.
SCL|Stepan Co|Price:57.570|Chg%:+0.050
Stepan Co (SCL) is trading at $57.570 with a slight increase of 0.09%. The company, a manufacturer of specialty and intermediate chemicals, shows healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Chemicals industry. Institutional ownership is very high, and one analyst has rated it as a Buy with a target price of $75.00.
